ACCEPTED MANUSCRIPT
6
Tetrahedron
N-(3-(Methoxymethoxy)phenyl)benzamide
(3l):
The
137.5, 130.8, 129.1, 128.4, 127.8, 124.6, 120.2; MS (ESI) m/z:
+
reaction of 1-iodo-3-(methoxymethoxy)benzene 1l (132.0 mg,
[M+H] 204.1.
0
9
2
.5 mmol) with benzonitrile 2a (103.0 mg, 1.0 mmol) afforded
N-phenylfuran-2-carboxamide (3s): The reaction of
iodobenzene 1a (102.0 mg, 0.5 mmol) with furan-2-carbonitrile
7.7 mg (76%) of 3l; IR(KBr) νmax 3306, 3087, 3068, 2991, 2946,
-
1 1
3
901, 2826, 1649, 1601, 1014 cm ; H NMR (400 MHz, CDCl ,
2
h (93.0 mg, 1.0 mmol) afforded 35.5 mg (38%) of 3s; IR:(KBr)
ppm) δ 7.90 (s, 1H), 7.87-7.84 (m, 2H), 7.55-7.52 (m, 1H), 7.50-
-1
ν
max 3435, 3282, 3141, 1655, 1599, 1479, 1324, 758 cm ;
7
3
1
9
.43 (m, 3H), 7.28-7.26 (m,2H), 6.85-6.81 (m, 1H), 5.19 (s, 2H),
.49 (s, 3H); C NMR (100 MHz, CDCl , ppm) δ 165.7, 157.8,
3
39.0, 134.9, 131.9, 129.9, 128.8, 127.0, 113.6, 112.5, 108.2,
4.4, 56.1; MS (ESI) m/z: [M+Na] 280.1.
1
13
3
HNMR (400 MHz, CDCl , ppm) δ 8.11 (s, 1H), 7.66 (d, J = 8.4
Hz, 2H), 7.52 (s, 1H), 7.38 (t, J = 7.6 Hz, 2H), 7.27-7.25 (m, 1H),
13
+
7.15 (t, J = 7.2 Hz, 1H), 6.58-6.57 (m, 1H); C NMR (100 MHz,
CDCl , ppm) δ 156.0, 147.7, 144.2, 137.3, 129.1, 124.5, 119.9,
3
+
2
-Methyl-N-phenylbenzamide (3m): The reaction of
iodobenzene 1a (102.0 mg, 0.5 mmol) with 2-methylbenzonitrile
b (117.1 mg, 1.0 mmol) afforded 59.1 mg (56%) of 3m;
IR(KBr) νmax 3286, 1652, 1597, 1533, 1439, 1321, 1260, 889,
115.3, 112.6; MS (ESI) m/z: [M+H] 188.2.
N-phenylpentanamide (3t): The reaction of iodobenzene 1a
2
(
102.0 mg, 0.5 mmol) with pentanenitrile 2i (83.0 mg, 1.0 mmol)
-
1
1
afforded 45.1 mg (51%) of 3t; IR(KBr) νmax 3246, 2931, 1657,
757 cm ; H NMR (400 MHz, CDCl
3
, ppm) δ 7.61 (d, J = 7.6
-1 1
1
547, 760 cm ; H NMR (400 MHz, CDCl
3
, ppm) δ 8.48 (s, 1H),
Hz, 2H), 7.57 (s, 1H), 7.45 (d, J = 7.2 Hz, 1H), 7.36 (t, J = 8.0
Hz, 3H), 7.26-7.22 (m,2H), 7.14 (t, J = 7.2 Hz, 1H), 2.49 (s, 3H);
7.54 (d, J = 8.0 Hz, 2H), 7.27-7.23 (m, 2H), 7.08-7.04 (m, 1H),
13
2.32 (t, J = 7.6 Hz, 2H), 1.69-1.62 (m, 2H), 1.38-1.29 (m, 2H),
13
C NMR (100 MHz, CDCl
3
, ppm) δ 168.1, 138.0, 136.3, 136.3,
0
.88 (t, J = 7.2 Hz, 3H); C NMR (100 MHz, CDCl
3
, ppm) δ
131.1, 130.2, 129.0, 126.6, 125.8, 124.4, 119.9, 19.7; MS (ESI)
+
172.3, 138.1, 128.6, 123.9, 120.1, 37.1, 27.7, 22.2, 13.7; MS
m/z: [M+H] 212.1.
+
(
ESI) m/z: [M+Na] 200.1.
3
-Methyl-N-phenylbenzamide (3n): The reaction of
N-phenylisobutyramide (3u): The reaction of iodobenzene 1a
102.0 mg, 0.5 mmol) with isobutyronitrile 2j (69.0 mg, 1.0
iodobenzene 1a (102.0 mg, 0.5 mmol) with 3-methylbenzonitrile
c (117.1 mg, 1.0 mmol) afforded 89.0 mg (84%) of 3n; IR(KBr)
max 3266, 1650, 1597, 1541, 1490, 1442, 1328, 856, 754 cm ;
H NMR (400 MHz, CDCl
.64 (d, J = 7.2 Hz, 3H), 7.39-7.36 (m, 4H), 7.15 (t, J = 7.2 Hz,
H), 2.43 (s, 3H); C NMR (100 MHz, CDCl , ppm) δ 166.0,
3
38.6, 138.0, 134.9, 132.5, 129.0, 128.6, 127.8, 124.5, 123.9,
20.2, 21.3; MS (ESI) m/z: [M+H] 212.1.
(
2
-
1
mmol) afforded 42.4 mg (52%) of 3u; IR(KBr) νmax 3301, 3263,
ν
-1 1
1
1662, 1549, 1442, 759 cm ; H NMR (400 MHz, CDCl
3
, ppm) δ
3
, ppm) δ 7.84 (s, 1H), 7.69 (s, 1H),
7
.54 (d, J = 7.6 Hz, 2H), 7.48 (s, 1H), 7.32-7.26 (m, 2H), 7.11-
7
1
1
1
13
1
3
7.07 (m, 1H), 2.55-2.49 (m, 1H), 1.24 (d, J = 6.8 Hz, 6H);
NMR (100 MHz, CDCl , ppm) δ 175.4, 138.0, 128.9, 124.1,
119.8, 36.6, 19.6; MS (ESI) m/z: [M+Na] 186.0.
C
3
+
+
4
.3 General procedure for the synthesis of benzoxazoles
4
-Methyl-N-phenylbenzamide (3o): The reaction of
iodobenzene 1a (102.0 mg, 0.5 mmol) with 4-methylbenzonitrile
d (117.1 mg, 1.0 mmol) afforded 90.8 mg (86%) of 3o; IR(KBr)
To a suspension of CuI (9.5 mg, 0.05 mmol), K CO (207.3
2
3
2
mg, 1.5 mmol) in toluene (2.0 mL) were added aryl o-dihalides 1
0.5 mmol), nitrile 2 (1.0 mmol), DMEDA (8.0 uL, 0.075 mmol),
-
1
1
ν
max 3352, 1650, 1524, 754 cm ; H NMR (400 MHz, CDCl
ppm) δ 7.82 (s, 1H), 7.77 (d, J = 8.0 Hz, 2H), 7.65-7.63 (m, 2H),
.39-7.35 (m, 2H), 7.28 (d, J = 8.0 Hz, 2H), 7.17-7.13 (m, 1H),
.43 (s, 3H); C NMR (100 MHz, CDCl
38.0, 132.1, 129.4, 129.1, 127.0, 124.4, 120.1, 21.5; MS (ESI)
m/z: [M+Na] 234.1.
3
,
(
acetaldoxime (92.0 uL, 1.5 mmol) under argon. The reaction
mixture was stirred for 15 h at 120 ℃ under argon. The solution
was cooled to room temperature and the solvent was removed
under vacuum. The crude product was purified by column
chromatography on silica gel (eluent: petroleum ether / ethyl
acetate = 30:1) to afford the benzoxazoles 4.
7
2
1
13
3
, ppm) δ 165.7, 142.4,
+
4-Chloro-N-phenylbenzamide (3p): The reaction of
iodobenzene 1a (102.0 mg, 0.5 mmol) with 4-chlorobenzonitrile
e (92.0 mg, 1.0 mmol) afforded 98.6 mg (85%) of 3p; IR(KBr)
2
-Phenylbenzoxazole (4a): The reaction of 1,2-diiodobenzene
m (141.5 mg, 0.5 mmol) with benzonitrile 2a (103.0 mg, 1.0
mmol) afforded 80.0 mg (82%) of 4a; IR(KBr) νmax 3060, 1551,
2
1
1
νmax 3353, 1653, 1599, 1487, 1439, 847, 755; H NMR (400MHz,
DMSO-d6, ppm) δ 10.32 (s, 1H), 7.99 (d, J=8.8Hz, 2H), 7.77 (d,
J=8Hz, 2H), 7.62 (d, J=8.4Hz, 2H), 7.36 (t, J=7.6Hz, 2H), 7.11(t,
-1
1
1
446, 744 cm ; H NMR (400 MHz, CDCl
m, 2H), 7.80-7.78 (m, 1H), 7.61-7.53 (m, 4H), 7.37-7.35 (m,
H); C NMR (100 MHz, CDCl , ppm) δ 163.0, 150.7, 141.9,
31.6, 128.9, 127.6, 127.0, 125.1, 124.6, 120.0, 110.6; MS (ESI)
3
, ppm) δ 8.28-8.26
(
2
13
J=7.6Hz, 1H); C NMR (100 MHz, DMSO-d6, ppm) δ 164.4,
39.0, 136.4, 133.6, 129.6, 128.6, 128.5, 123.8, 120.4; MS (ESI)
13
3
1
1
+
m/z: [M+H] 232.1.
+
m/z: [M+H] 196.1.
4
-Fluoro-N-phenylbenzamide (3q): The reaction of
2
-o-Tolylbenzoxazole (4b): The reaction of 1,2-diiodobenzene
m (141.5 mg, 0.5 mmol) with 2-methylbenzonitrile 2b (117.2
mg, 1.0 mmol) afforded 57.9 mg (55%) of 4b; IR(KBr) νmax
iodobenzene 1a (102.0 mg, 0.5 mmol) with 4-fluorobenzonitrile
f (121.0 mg, 1.0 mmol) afforded 97.9 mg (91%) of 3q; IR(KBr)
max 3353, 1655, 1506, 752 cm ; H NMR (400 MHz, DMSO-d6,
ppm) δ 10.28 (s, 1H), 8.08-8.03 (m, 2H), 7.80-7.77 (m, 2H),
.41-7.34 (m, 4H), 7.13-7.10 (m, 1H); C NMR (100 MHz,
DMSO-d6, ppm) δ 165.3, 164.4, 162.8, 139.1, 131.4 (d, J = 3.2
Hz), 130.4 (d, J = 8.3 Hz), 128.6, 123.7, 120.4, 115.3 (d, J = 21.8
Hz); MS (ESI) m/z: [M+H] 216.1.
1
2
ν
-
1 1
-1 1
3
8
7
1
1
060, 1551, 1446, 744 cm ; H NMR (400 MHz, CDCl , ppm) δ
.19-8.17 (m, 1H), 7.82-7.80 (m, 1H), 7.61-7.58 (m, 1H), 7.42-
.26 (m, 5H), 2.82 (s, 3H); C NMR (100 MHz, CDCl
63.4, 150.2, 142.1, 138.8, 131.8, 130.9, 129.9, 126.2, 126.0,
3
13
7
13
3
, ppm) δ
+
25.0, 124.4, 120.1, 110.5, 22.2; MS (ESI) m/z: [M+H] 210.1.
+
2
-m-Tolylbenzoxazole (4c): The reaction of 1,2-
N-Phenylthiophene-2-carboxamide (3r): The reaction of
iodobenzene 1a (102.0 mg, 0.5 mmol) with thiophene-2-
carbonitrile 2g (109.2 mg, 1.0 mmol) afforded 63.9 mg (63%) of
diiodobenzene 1m (141.5 mg, 0.5 mmol) with 3-
methylbenzonitrile 2c (117.1 mg, 1.0 mmol) afforded 89.9mg
86%) of 4c; IR(KBr) νmax 3433, 1551, 1446, 744 cm ; H NMR
400 MHz, CDCl , ppm) δ 8.11 (s, 1H), 8.05 (d, J = 7.6 Hz, 1H),
.79-7.77 (m, 1H), 7.60-7.58 (m, 1H), 7.42 (t, J = 8.0 Hz, 1H),
-1
1
(
(
7
7
-1
3
r; IR(KBr) νmax 3303, 1631, 1595, 1535, 1445, 1323, 755 cm ;
1
3
H NMR (400 MHz, CDCl
3
, ppm) δ 7.75 (s, 1H), 7.64-7.61 (m,
3
H), 7.55 (d, J = 5.2 Hz, 1H), 7.36 (t, J = 7.2 Hz, 2H), 7.17-7.12
13
3
.38-7.35 (m, 3H), 2.46 (s, 3H); C NMR (100 MHz, CDCl ,
1
3
(
3
m, 2H); C NMR (100 MHz, CDCl , ppm) δ 159.9, 139.2,